MedPath

Combination Therapy With Biofeedback, Loperamide and Stool Bulking Agents

Not Applicable
Completed
Conditions
Fecal Incontinence
Interventions
Behavioral: Biofeedback
Other: Combination of biofeedback and medical treatment
Drug: Stool bulking agent (stericulia or isphagula husk)
Registration Number
NCT02165475
Lead Sponsor
University Hospital, Linkoeping
Brief Summary

Background: Biofeedback and medical treatments have been extensively used for moderate fecal incontinence. There is limited data comparing and combining these two treatments.

Aim: To evaluate the effect of biofeedback and medical treatments, separately and in combination.

Methods: Sixty-five consecutive female patients, referred to a tertial center for fecal incontinence were included. The patients were randomized to start with either biofeedback (4-6 months) or medical treatment with loperamide and stool-bulking agents (2 months). Both groups continued with a combination treatments, i.e. medical treatment was added to biofeedback and vice versa. A two-week prospective bowel symptom diary and anorectal physiology were evaluated at baseline, after single- and combination treatments.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria
  • Patients older than 18 years of age
  • Patients with at least one or more episodes of FI during a period of 2 weeks as recorded by bowel function diary
  • Patients from whom written consent was obtained
Exclusion Criteria
  • Previous congenital or acquired spinal injury, spinal tumour or spinal surgery
  • Presence of neurological diseases or peripheral vascular disease
  • Uncontrolled diabetes mellitus
  • Congenital anorectal malformations
  • Recent colorectal or gastrointestinal surgery
  • Presence of external full-thickness rectal prolapse
  • Inflammatory bowel disease
  • Chronic diarrhoea
  • Use of tibial nerve or sacral nerve stimulations
  • Ongoing pregnancy
  • Any malignant disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
BiofeedbackBiofeedback-
medical treatmentStool bulking agent (stericulia or isphagula husk)-
combination of the two treatmentsCombination of biofeedback and medical treatment-
medical treatmentLoperamide-
Primary Outcome Measures
NameTimeMethod
symptom diaryUp to eight months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Pelvic floor unit, University hospital of Linköping

🇸🇪

Linköping, Sweden

© Copyright 2025. All Rights Reserved by MedPath